Please enable JavaScript to continue using this application.

Compare $NKTX vs $ORGO | Chartloom

Compare

$NKTX vs $ORGO

Nkarta Inc · Organogenesis Holdings Inc

NKTX

Nkarta Inc

ORGO

Organogenesis Holdings Inc

Compare $NKTX vs $ORGO

Comparing Nkarta Inc and Organogenesis Holdings Inc

NKTXNkarta Inc

ORGOOrganogenesis Holdings Inc

NKTXNkarta Inc

Market cap

$161M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

20.3%

52W performance

7.7%

FCF yield

-58.3%

ORGOOrganogenesis Holdings Inc

Market cap

$166M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

0.74x

Rev growth (TTM)

6.5%

YTD performance

-72.2%

52W performance

-68.8%

FCF yield

12.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

NKTX

ORGO

Detailed metrics comparison

NKTX

Nkarta Inc

ORGO

Organogenesis Holdings Inc

Market Cap

NKTX$161M

ORGO$166M

Enterprise Value

NKTX$136M

ORGO$132M

Price

NKTX$2.25

ORGO$1.29

P/E Ratio

NKTXN/A

ORGON/A

P/S Ratio

NKTX0.00x

ORGO0.36x

EV/Sales

NKTX0.00x

ORGO0.29x

EV/EBITDA

NKTX0.00x

ORGO7.37x

P/B Ratio

NKTX0.74x

ORGO0.59x

P/FCF Ratio

NKTXN/A

ORGO7.96x

EV/FCF

NKTX-1.45x

ORGO6.31x

PEG Ratio

NKTXN/A

ORGON/A

Forward P/E (NTM)

NKTXN/A

ORGON/A

Forward P/S (NTM)

NKTXN/A

ORGO0.74x

Revenue (TTM)

NKTX$0

ORGO$457M

Revenue Growth (YoY)

NKTXN/A

ORGO6.5%

Forward Rev Growth

NKTX2561.2%

ORGO37.6%

Gross Margin (TTM)

NKTX0.0%

ORGO70.4%

Operating Margin (TTM)

NKTX0.0%

ORGO0.0%

EBITDA Margin (TTM)

NKTX0.0%

ORGO-2.0%

Net Margin (TTM)

NKTX0.0%

ORGO-23.1%

FCF Margin (TTM)

NKTXN/A

ORGO4.6%

Net Income (TTM)

NKTX$-117M

ORGO$-106M

FCF (TTM)

NKTX$-94M

ORGO$21M

EPS (TTM)

NKTX-$1.57

ORGO-$0.82

ROE (TTM)

NKTX-3964.0%

ORGO-2260.0%

ROA (TTM)

NKTX-3045.0%

ORGO-1654.0%

ROIC (TTM)

NKTX-3964.0%

ORGO-2187.0%

Cash

NKTX$25M

ORGO$46M

Debt

NKTX$0

ORGO$12M

Net Cash/Debt

NKTX$25M

ORGO$34M

Current Ratio (TTM)

NKTX7.98x

ORGO3.52x

Quick Ratio (TTM)

NKTX7.76x

ORGO2.66x

Debt/Equity (TTM)

NKTX0.00x

ORGO0.04x

Debt/Assets (TTM)

NKTX0.0%

ORGO0.0%

Interest Coverage (TTM)

NKTXN/A

ORGON/A

Net Debt/EBITDA (TTM)

NKTX0.00x

ORGO0.00x

Beta

NKTX1.19

ORGO1.44

52W Performance

NKTX7.7%

ORGO-68.8%

YTD Performance

NKTX20.3%

ORGO-72.2%

% from 52W High

NKTX-39.5%

ORGO-81.8%

% from 52W Low

NKTX32.4%

ORGO3.2%

Asset Turnover (TTM)

NKTX0.00x

ORGO0.90x

FCF Yield (TTM)

NKTX-58.3%

ORGO12.6%

Earnings Yield (TTM)

NKTX-72.9%

ORGO-63.8%

Dividend Yield (TTM)

NKTXN/A

ORGON/A

Rule of 40

NKTX0.0

ORGO11.1

EV/GP/RG

NKTXN/A

ORGO0.01

Ticker research

View NKTX research View ORGO research

Metric	NKTX Nkarta Inc	ORGO Organogenesis Holdings Inc
Market & Valuation
Market Cap	$161M	$166M
Enterprise Value	$136M	$132M
Price	$2.25	$1.29
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.36x
EV/Sales	0.00x	0.29x
EV/EBITDA	0.00x	7.37x
P/B Ratio	0.74x	0.59x
P/FCF Ratio	N/A	7.96x
EV/FCF	-1.45x	6.31x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	0.74x
Revenue & Growth
Revenue (TTM)	$0	$457M
Revenue Growth (YoY)	N/A	6.5%
Forward Rev Growth	2561.2%	37.6%
Profitability
Gross Margin (TTM)	0.0%	70.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-2.0%
Net Margin (TTM)	0.0%	-23.1%
FCF Margin (TTM)	N/A	4.6%
Net Income (TTM)	$-117M	$-106M
FCF (TTM)	$-94M	$21M
EPS (TTM)	-$1.57	-$0.82
ROE (TTM)	-3964.0%	-2260.0%
ROA (TTM)	-3045.0%	-1654.0%
ROIC (TTM)	-3964.0%	-2187.0%
Financial Health
Cash	$25M	$46M
Debt	$0	$12M
Net Cash/Debt	$25M	$34M
Current Ratio (TTM)	7.98x	3.52x
Quick Ratio (TTM)	7.76x	2.66x
Debt/Equity (TTM)	0.00x	0.04x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.19	1.44
52W Performance	7.7%	-68.8%
YTD Performance	20.3%	-72.2%
% from 52W High	-39.5%	-81.8%
% from 52W Low	32.4%	3.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.90x
FCF Yield (TTM)	-58.3%	12.6%
Earnings Yield (TTM)	-72.9%	-63.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	11.1
EV/GP/RG	N/A	0.01
Ticker research	View NKTX research	View ORGO research

Valuation

P/S Ratio

NKTX

0.00x

ORGO

0.36x

EV/FCF

NKTX

-1.45x

ORGO

6.31x

Growth & revenue

Revenue Growth TTM

ORGO

6.5%

Forward Revenue Growth

NKTX

2561.2%

ORGO

37.6%

Profitability & performance

Gross Margin

ORGO

70.4%

NKTX

0.0%

ROE

ORGO

-2260.0%

NKTX

-3964.0%

FCF Yield %

ORGO

12.6%

NKTX

-58.3%

52-Week Performance

NKTX

7.7%

ORGO

-68.8%

Detailed metrics comparison

NKTX

Nkarta Inc

ORGO

Organogenesis Holdings Inc

Market Cap

NKTX$161M

ORGO$166M

Enterprise Value

NKTX$136M

ORGO$132M

Price

NKTX$2.25

ORGO$1.29

P/E Ratio

NKTXN/A

ORGON/A

P/S Ratio

NKTX0.00x

ORGO0.36x

EV/Sales

NKTX0.00x

ORGO0.29x

EV/EBITDA

NKTX0.00x

ORGO7.37x

P/B Ratio

NKTX0.74x

ORGO0.59x

P/FCF Ratio

NKTXN/A

ORGO7.96x

EV/FCF

NKTX-1.45x

ORGO6.31x

PEG Ratio

NKTXN/A

ORGON/A

Forward P/E (NTM)

NKTXN/A

ORGON/A

Forward P/S (NTM)

NKTXN/A

ORGO0.74x

Revenue (TTM)

NKTX$0

ORGO$457M

Revenue Growth (YoY)

NKTXN/A

ORGO6.5%

Forward Rev Growth

NKTX2561.2%

ORGO37.6%

Gross Margin (TTM)

NKTX0.0%

ORGO70.4%

Operating Margin (TTM)

NKTX0.0%

ORGO0.0%

EBITDA Margin (TTM)

NKTX0.0%

ORGO-2.0%

Net Margin (TTM)

NKTX0.0%

ORGO-23.1%

FCF Margin (TTM)

NKTXN/A

ORGO4.6%

Net Income (TTM)

NKTX$-117M

ORGO$-106M

FCF (TTM)

NKTX$-94M

ORGO$21M

EPS (TTM)

NKTX-$1.57

ORGO-$0.82

ROE (TTM)

NKTX-3964.0%

ORGO-2260.0%

ROA (TTM)

NKTX-3045.0%

ORGO-1654.0%

ROIC (TTM)

NKTX-3964.0%

ORGO-2187.0%

Cash

NKTX$25M

ORGO$46M

Debt

NKTX$0

ORGO$12M

Net Cash/Debt

NKTX$25M

ORGO$34M

Current Ratio (TTM)

NKTX7.98x

ORGO3.52x

Quick Ratio (TTM)

NKTX7.76x

ORGO2.66x

Debt/Equity (TTM)

NKTX0.00x

ORGO0.04x

Debt/Assets (TTM)

NKTX0.0%

ORGO0.0%

Interest Coverage (TTM)

NKTXN/A

ORGON/A

Net Debt/EBITDA (TTM)

NKTX0.00x

ORGO0.00x

Beta

NKTX1.19

ORGO1.44

52W Performance

NKTX7.7%

ORGO-68.8%

YTD Performance

NKTX20.3%

ORGO-72.2%

% from 52W High

NKTX-39.5%

ORGO-81.8%

% from 52W Low

NKTX32.4%

ORGO3.2%

Asset Turnover (TTM)

NKTX0.00x

ORGO0.90x

FCF Yield (TTM)

NKTX-58.3%

ORGO12.6%

Earnings Yield (TTM)

NKTX-72.9%

ORGO-63.8%

Dividend Yield (TTM)

NKTXN/A

ORGON/A

Rule of 40

NKTX0.0

ORGO11.1

EV/GP/RG

NKTXN/A

ORGO0.01

Ticker research

View NKTX research View ORGO research

Metric	NKTX Nkarta Inc	ORGO Organogenesis Holdings Inc
Market & Valuation
Market Cap	$161M	$166M
Enterprise Value	$136M	$132M
Price	$2.25	$1.29
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.36x
EV/Sales	0.00x	0.29x
EV/EBITDA	0.00x	7.37x
P/B Ratio	0.74x	0.59x
P/FCF Ratio	N/A	7.96x
EV/FCF	-1.45x	6.31x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	0.74x
Revenue & Growth
Revenue (TTM)	$0	$457M
Revenue Growth (YoY)	N/A	6.5%
Forward Rev Growth	2561.2%	37.6%
Profitability
Gross Margin (TTM)	0.0%	70.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-2.0%
Net Margin (TTM)	0.0%	-23.1%
FCF Margin (TTM)	N/A	4.6%
Net Income (TTM)	$-117M	$-106M
FCF (TTM)	$-94M	$21M
EPS (TTM)	-$1.57	-$0.82
ROE (TTM)	-3964.0%	-2260.0%
ROA (TTM)	-3045.0%	-1654.0%
ROIC (TTM)	-3964.0%	-2187.0%
Financial Health
Cash	$25M	$46M
Debt	$0	$12M
Net Cash/Debt	$25M	$34M
Current Ratio (TTM)	7.98x	3.52x
Quick Ratio (TTM)	7.76x	2.66x
Debt/Equity (TTM)	0.00x	0.04x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.19	1.44
52W Performance	7.7%	-68.8%
YTD Performance	20.3%	-72.2%
% from 52W High	-39.5%	-81.8%
% from 52W Low	32.4%	3.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.90x
FCF Yield (TTM)	-58.3%	12.6%
Earnings Yield (TTM)	-72.9%	-63.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	11.1
EV/GP/RG	N/A	0.01
Ticker research	View NKTX research	View ORGO research